SOURCE: Solei Systems, Inc.
|
August 11, 2008 07:00 ET
Solei Systems, Inc. Announces Preliminary FDA Compliance of Its Patent Pending Light Therapy System
BOCA RATON, FL--(Marketwire - August 11, 2008) - Solei Systems, Inc. (PINKSHEETS: SOLI) (the
"Company") announced today that its patent pending liquid cooled "LED"
phototherapy machine has met the preliminary FDA requirements. The Company
has entered into an agreement with an FDA approved independent consulting
and testing laboratory to conduct the remaining tests in order to obtain
final 510(k) FDA Clearance, UL approval, CSA C22.2 #601.1, IEC 60601-1, IEC
60601-1-2, CENELEC EN 60601-1, and the CE mark. The compliance with
international regulations should further increase foreign exports.
The Company's patent pending liquid cooling technology allows for much
greater output levels than previous existing technology, resulting in more
dramatic results in less time.
Safe Harbor Statement
Certain statements set forth in this press release constitute
"forward-looking statements." Forward-looking statements include, without
limitation, any statement that may predict, forecast, indicate, or imply
future results, performance or achievements, and may contain the words
"estimate," "project," "intend," "forecast," "anticipate," "plan,"
"planning," "expect," "believe," "will likely," "should," "could," "would,"
"may" or words or expressions of similar meaning. Such statements are not
guarantees of future performance and are subject to risks and uncertainties
that could cause the company's actual results and financial position to
differ materially from those included within the forward-looking
statements. Forward-looking statements involve risks and uncertainties,
including those relating to the Company's ability to grow its business.
Actual results may differ materially from the results predicted and
reported results should not be considered as an indication of future
performance. The potential risks and uncertainties include, among others,
the Company's limited operating history, the limited financial resources,
domestic or global economic conditions -- activities of competitors and the
presence of new or additional competition and conditions of equity markets.